post induction chemotherapy
Showing 1 - 25 of >10,000
Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)
Recruiting
- Nasopharyngeal Cancer
- Toripalimab
- Induction chemotherapy and concurrent chemoradiation
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Nov 25, 2022
Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1
Recruiting
- Nasopharyngeal Carcinoma
- De-escalation Therapy
- Cisplatin-based induction chemotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 16, 2023
Stage IV Pancreatic Cancer Trial in Ramat Gan (Nivolumab, ipilimumab, Stereotactic body radiation therapy)
Not yet recruiting
- Stage IV Pancreatic Cancer
- Nivolumab
- +3 more
-
Ramat Gan, IsraelSheba Medical Centre
Oct 10, 2021
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023
Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Mouth Neoplasms
- Carcinoma, Squamous Cell
- TPF induction chemotherapy
- +2 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022
Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Mouth Neoplasms
- Carcinoma, Squamous Cell
- TPF group
- +2 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, Shanghai Jiao Tong University School of
Oct 5, 2022
Nasopharyngeal Carcinoma, Induction Chemo, Radiotherapy Trial in Foshan, Zhongshan (Delineating the GTV according to the
Recruiting
- Nasopharyngeal Carcinoma
- +2 more
- Delineating the GTV according to the pretreatment or post-IC tumor extension
-
Foshan, China
- +1 more
Mar 18, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- 2 cycles induction chemotherapy
- 3 cycles induction chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaFirst Affiliated Hospital, Sun Yat-Sen University
May 6, 2023
Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)
Not yet recruiting
- Acute Myeloid Leukemia
- Different induction chemotherapy regimens
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 27, 2023
Nasopharyngeal Carcinoma, De-escaltion Therapy Trial in Guangzhou (Reduced-target resection, Full-target resection, Adjuvant
Recruiting
- Nasopharyngeal Carcinoma
- De-escaltion Therapy
- Reduced-target resection
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 25, 2023
Post Induction Hypotension Trial in Jamshedpur (RL 10ml/kg, RL 15ml/kg)
Recruiting
- Post Induction Hypotension
- RL 10ml/kg
- RL 15ml/kg
-
Jamshedpur, Jharkhand, IndiaAbhishek Chatterjee
Jun 28, 2023
Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Mouth Neoplasms
- Carcinoma, Squamous Cell
- TPF induction chemotherapy
- +2 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)
Recruiting
- Cervical Cancer
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Oct 16, 2023
Anesthesia, Blood Pressure, Norepinephrine Trial (Norepinephrine Hydrochloride, Placebo)
Not yet recruiting
- Anesthesia
- +2 more
- Norepinephrine Hydrochloride
- Placebo
- (no location specified)
Aug 31, 2023
Oral Cancer, Induction Chemo, Programmed Cell Death 1 Inhibitor Trial in Shanghai (drug, procedure, radiation)
Active, not recruiting
- Oral Cancer
- +3 more
- Toripalimab
- +4 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Nov 17, 2021
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
General Anesthesia, Hemodynamic Instability Trial in Istanbul (Manual anesthesia induction, Anesthesia induction with Target
Recruiting
- General Anesthesia
- Hemodynamic Instability
- Manual anesthesia induction
- Anesthesia induction with Target controlled infusions (TCI)
-
Istanbul, TurkeyAcibadem Altunizade Hospital
Feb 2, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)
Not yet recruiting
- Secondary Acute Myeloid Leukemia
- Venetoclax
- FLAG Protocol
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Mar 22, 2023
Post-induction Hypotension
Active, not recruiting
- Hypotension on Induction
-
Taipei, TaiwanDepartment of Anesthesia, Taipei Medical University Hospital
Feb 23, 2023
Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)
Recruiting
- Neoplasm Neck
- docetaxel, cisplatin and 5-fluorouracil
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022